Crossmark

Unraveling the rationale and conducting a comprehensive assessment of AdipoRon (adiponectin receptor agonist) as a candidate drug for diabetic nephropathy and cardiomyopathy prevention and intervention—a systematic review

Crossref DOI link: https://doi.org/10.1007/s00210-024-03362-7

Published Online: 2024-08-13

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Laurindo, Lucas Fornari

Laurindo, Lívia Fornari

Rodrigues, Victória Dogani

Catharin, Virgínia Maria Cavallari Strozze

Simili, Otávio Augusto Garcia

Barboza, Gabriella Oliveira

Catharin, Vitor Cavallari Strozze

Sloan, Kátia Portero

Barbalho, Sandra Maria
License Information

Text and Data Mining valid from 2024-08-13

Version of Record valid from 2024-08-13
More Information

Article History

Received: 23 July 2024

Accepted: 6 August 2024

First Online: 13 August 2024

Declarations

:

: Not applicable.

: The authors declare no competing interests.

: This article does not contain any studies with human and animal subjects performed by any of the authors.

Document is current

Any future updates will be listed below